IRLAB’s IRL790 receives new name ‘mesdopetam’
IRLAB has decided to use the name mesdopetam for its drug candidate IRL790 following the recommendation for International Nonproprietary Name (INN) by the World Health Organization (WHO). WHO concluded that IRL790 is wholly unique in its mechanism of action and has, therefore, assigned IRL790 a new INN that can become a new substance class in the existing classification system for pharmaceutical substances. The INN will serve to identify the active pharmaceutical substance mesdopetam (IRL790) worldwide.Nicholas Waters, CEO at IRLAB, commented “It is gratifying that IRL790 has been